Madison Davis

642 total citations
8 papers, 100 citations indexed

About

Madison Davis is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Madison Davis has authored 8 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Madison Davis's work include CAR-T cell therapy research (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Trypanosoma species research and implications (2 papers). Madison Davis is often cited by papers focused on CAR-T cell therapy research (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Trypanosoma species research and implications (2 papers). Madison Davis collaborates with scholars based in United States. Madison Davis's co-authors include Brendan D. Stamper, Sigrid C. Roberts, Jan M. Boitz, Michael K. Riscoe, Buddy Ullman, Caslin A. Gilroy, Phillip A. Yates, Yuexin Li, Peter Zuber and Roger A. Williams and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Madison Davis

8 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madison Davis United States 5 59 53 28 20 12 8 100
Alison Mbekeani United Kingdom 5 60 1.0× 43 0.8× 24 0.9× 9 0.5× 6 0.5× 7 110
Rifat Rahman United States 7 86 1.5× 20 0.4× 17 0.6× 5 0.3× 5 0.4× 12 124
Nina Mattock United Kingdom 4 114 1.9× 83 1.6× 27 1.0× 25 1.3× 5 0.4× 10 149
Sonja Bernhard Switzerland 4 57 1.0× 67 1.3× 17 0.6× 24 1.2× 3 0.3× 5 86
Eric Gaukel United States 5 69 1.2× 68 1.3× 42 1.5× 77 3.9× 6 152
Fabiana Barreira Argentina 5 104 1.8× 138 2.6× 27 1.0× 45 2.3× 3 0.3× 6 159
Anjo Theron South Africa 3 73 1.2× 11 0.2× 43 1.5× 18 0.9× 2 0.2× 6 117
Nimisha Mittal United States 5 45 0.8× 20 0.4× 30 1.1× 9 0.5× 1 0.1× 10 82
Timothy M. Freeman United Kingdom 3 55 0.9× 47 0.9× 11 0.4× 9 0.5× 3 63
Marcela L. Moreira Brazil 8 39 0.7× 33 0.6× 22 0.8× 3 0.1× 8 0.7× 13 133

Countries citing papers authored by Madison Davis

Since Specialization
Citations

This map shows the geographic impact of Madison Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madison Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madison Davis more than expected).

Fields of papers citing papers by Madison Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madison Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madison Davis. The network helps show where Madison Davis may publish in the future.

Co-authorship network of co-authors of Madison Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Madison Davis. A scholar is included among the top collaborators of Madison Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madison Davis. Madison Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Davis, Madison, et al.. (2024). 252 Pre-treatment IL-15 serum levels correlate with the incidence and severity of neurological events following the administration of anti-CD19 CAR-T cells. Regular and Young Investigator Award Abstracts. A290–A290. 1 indexed citations
2.
Jain, Michael D., David B. Miklos, Caron A. Jacobson, et al.. (2023). Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11. Clinical Cancer Research. 29(20). 4118–4127. 6 indexed citations
3.
Stamper, Brendan D., et al.. (2019). Model-based Evaluation of Gene Expression Changes in Response to Leishmania Infection. SHILAP Revista de lepidopterología. 13. 821839998–821839998. 5 indexed citations
5.
Boitz, Jan M., Caslin A. Gilroy, Madison Davis, et al.. (2016). Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes. Infection and Immunity. 85(1). 62 indexed citations
6.
Davis, Madison & Brendan D. Stamper. (2016). TAMH: A Useful In Vitro Model for Assessing Hepatotoxic Mechanisms. BioMed Research International. 2016. 1–9. 15 indexed citations
7.
Davis, Madison, et al.. (2016). Overcoming Chemoresistance in Pancreatic Cancer by Targeting the Anti‐Apoptotic Mcl‐1 Protein. The FASEB Journal. 30(S1). 1 indexed citations
8.
Williams, Roger A. & Madison Davis. (1977). Clinical and experimental aspects of paracetamol hepatotoxicity.. PubMed. 41 Suppl 2. 282–98. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026